Search

16/03/2026 TFE3-Rearranged and TFEB-Altered Renal Cell Carcinomas: Molecular Landscape and Therapeutic Advances
Portu, M, Balsa, M, Cotaina, M, Anguera, G, del Muro, XG, Algaba, F, Maroto, P. TFE3-Rearranged and TFEB-Altered Renal Cell Carcinomas: Molecular Landscape and Therapeutic Advances. Cancers. 2026; 18(6)DOI:10.3390/cancers18060958. PMID:41899560. IF:4.400(Q2/3D).
01/01/2025 Precision targeting of CXCR4+leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model.
Garcia-Leon, Annabel, Mendoza, Julian I, Rueda, Ariana, Alba-Castellon, Lorena, Nomdedeu, Josep F, Gallardo, Alberto, Sierra, Jorge, Garrido, Ana, Vazquez, Esther, Villaverde, Antonio, Mangues, Ramon, Unzueta, Ugutz, Casanova, Isolda. Precision targeting of CXCR4+leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2025; 192DOI:10.1016/j.biopha.2025.118573. PMID:. IF:(Q/D).
01/09/2024 Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles
Parladé, E, García-Leon, A, Voltà-Durán, E, Unzueta, U, Mangues, R, Casanova, I, Villaverde, A, Váquez, E. Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2024; 202DOI:10.1016/j.ejpb.2024.114410. PMID:39004320. IF:4.300(Q1/2D).
01/12/2022 Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera (vol 101, 2231, 2022)
Triguero, A, Pedraza, A, Perez-Encinas, M, Mata-Vazquez, MI, Velez, P, Fox, L, Gomez-Calafat, M, Garcia-Delgado, R, Gasior, M, Ferrer-Marin, F, Garcia-Gutierrez, V, Angona, A, Gomez-Casares, MT, Cuevas, B, Martinez, C, Perez, R, Raya, JM, Guerrero, L, Murillo, I, Bellosillo, B, Hernandez-Boluda, JC, Sanz, C, Alvarez-Larran, A. Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera (vol 101, 2231, 2022). ANNALS OF HEMATOLOGY. 2022; 101(12)DOI:10.1007/s00277-022-05005-4. PMID:36264368. IF:3.500(Q2/5D).
01/01/2026 Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular
Fernández-Luis, S, Bermúdez, A, San Segundo, LY, González, MB, Asensio, SM, Esquirol, A, García-Cadenas, I, Pascual, MJ, Herruzo, B, Salas, MQ, Alburquerque-Prieto, C, Viguria-Alegría, MC, Pérez, A, Hernani, R, Mas, MH, Villalba, M, Calvo, CM, Fabbri, N, González-Rodriguez, AP, Bailén, R, Tomás, LG, Maño, LG, Salinas, AS, Calbacho, M, Bento, L, Balari, AS. Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular. TRANSPLANTATION. 2026; 110(1)DOI:10.1097/TP.0000000000005446. PMID:40524321. IF:5.000(Q1/1D).
01/12/2024 Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study
Abrisqueta-Costa, P, García-Marco, JA, Gutiérrez, A, Hernández-Rivas, JA, Andreu-Lapiedra, R, Arguello-Tomas, M, Leiva-Farré, C, López-Roda, MD, Callejo-Mellén, A, Alvarez-García, E, Loscertales, J. Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study. Cancers. 2024; 16(23)DOI:10.3390/cancers16234004. PMID:39682190. IF:4.400(Q2/3D).
01/01/2026 Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMT
Nagler, A, Galimard, JE, Kayser, S, Kulagin, A, Blaise, D, Parovichnikova, E, Versluis, J, Itäla-Remes, M, Choi, G, Bufarull, RM, Sica, S, Roeven, MWH, von dem Borne, P, Bazarbachi, A, Sanz, J, Mohty, M, Ciceri, F. Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMT. BONE MARROW TRANSPLANTATION. 2026; 61(1)DOI:10.1038/s41409-025-02726-8. PMID:41109900. IF:5.200(Q1/1D).
07/02/2024 Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis (vol 20, pg 917, 2018)
Madaro, L, Passafaro, M, Sala, D, Etxaniz, U, Lugarini, F, Proietti, D, Alfonsi, MV, Nicoletti, C, Gatto, S, De Bardi, M, Rojas-Garcia, R, Giordani, L, Marinelli, S, Pagliarini, V, Sette, C, Sacco, A, Puri, PL. Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis (vol 20, pg 917, 2018). NATURE CELL BIOLOGY. 2024; 26(3)DOI:10.1038/s41556-024-01365-3. PMID:38326555. IF:19.100(Q1/1D).